167 related articles for article (PubMed ID: 26116388)
1. Molecular docking study, synthesis and biological evaluation of Mannich bases as Hsp90 inhibitors.
Dutta Gupta S; Bommaka MK; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
Int J Biol Macromol; 2015 Sep; 80():253-9. PubMed ID: 26116388
[TBL] [Abstract][Full Text] [Related]
2. Molecular docking study, synthesis and biological evaluation of Schiff bases as Hsp90 inhibitors.
Dutta Gupta S; Snigdha D; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
Biomed Pharmacother; 2014 Apr; 68(3):369-76. PubMed ID: 24486109
[TBL] [Abstract][Full Text] [Related]
3. Rational Identification of Hsp90 Inhibitors as Anticancer Lead Molecules by Structure Based Drug Designing Approach.
Gupta SD; Swapanthi PS; Bhagya D; Federicci F; Mazaira GI; Galigniana MD; Subrahmanyam CVS; Gowrishankar NL; Raghavendra NM
Anticancer Agents Med Chem; 2020; 20(3):369-385. PubMed ID: 31713499
[TBL] [Abstract][Full Text] [Related]
4. 2,4-dihydroxy benzaldehyde derived Schiff bases as small molecule Hsp90 inhibitors: rational identification of a new anticancer lead.
Dutta Gupta S; Revathi B; Mazaira GI; Galigniana MD; Subrahmanyam CV; Gowrishankar NL; Raghavendra NM
Bioorg Chem; 2015 Apr; 59():97-105. PubMed ID: 25727264
[TBL] [Abstract][Full Text] [Related]
5. Drug Design, Synthesis and In Vitro Evaluation of Substituted Benzofurans as Hsp90 Inhibitors.
Kadasi S; Costa TEMM; Arukala N; Toshakani M; Duggineti C; Thota S; Dutta Gupta S; Raj S; Penido C; Henriques MG; Raghavendra NM
Med Chem; 2018; 14(1):44-52. PubMed ID: 28641528
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of pyrimidinyl acyl thioureas as novel Hsp90 inhibitors in invasive ductal breast cancer and its bone metastasis.
Koca İ; Özgür A; Er M; Gümüş M; Açikalin Coşkun K; Tutar Y
Eur J Med Chem; 2016 Oct; 122():280-290. PubMed ID: 27376491
[TBL] [Abstract][Full Text] [Related]
7. Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses.
Arodola OA; Soliman ME
Drug Des Devel Ther; 2015; 9():6055-65. PubMed ID: 26622167
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and molecular docking studies of novel pyrazolyl 2-aminopyrimidine derivatives as HSP90 inhibitors.
Mettu A; Talla V; Bajaj DM; Subhashini NJP
Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900063. PubMed ID: 31411362
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a novel class Hsp90 inhibitors containing 1-phenylpiperazine scaffold.
Jia JM; Liu F; Xu XL; Guo XK; Jiang F; Cherfaoui B; Sun HP; You QD
Bioorg Med Chem Lett; 2014 Mar; 24(6):1557-61. PubMed ID: 24582477
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors.
Zhao H; Garg G; Zhao J; Moroni E; Girgis A; Franco LS; Singh S; Colombo G; Blagg BS
Eur J Med Chem; 2015 Jan; 89():442-66. PubMed ID: 25462258
[TBL] [Abstract][Full Text] [Related]
11. COX-1/COX-2 inhibition activities and molecular docking study of newly designed and synthesized pyrrolo[3,4-c]pyrrole Mannich bases.
Redzicka A; Szczukowski Ł; Kochel A; Wiatrak B; Gębczak K; Czyżnikowska Ż
Bioorg Med Chem; 2019 Sep; 27(17):3918-3928. PubMed ID: 31345747
[TBL] [Abstract][Full Text] [Related]
12. Identification of New Hsp90 Inhibitors: Structure Based Virtual Screening, Molecular Dynamic Simulation, Synthesis and Biological Evaluation.
Abbasi M; Amanlou M; Aghaei M; Hassanzadeh F; Sadeghi-Aliabadi H
Anticancer Agents Med Chem; 2021; 21(18):2583-2591. PubMed ID: 33563187
[TBL] [Abstract][Full Text] [Related]
13. Targeting the entry region of Hsp90's ATP binding pocket with a novel 6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl amide.
Jeong JH; Oh YJ; Lho Y; Park SY; Liu KH; Ha E; Seo YH
Eur J Med Chem; 2016 Nov; 124():1069-1080. PubMed ID: 27783977
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Evaluation of Heat Shock Protein 90 Inhibitors in Human Breast Cancer and Its Metastasis.
Gümus M; Ozgur A; Tutar L; Disli A; Koca I; Tutar Y
Curr Pharm Biotechnol; 2016; 17(14):1231-1245. PubMed ID: 27804852
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative activity of imidazo[1,2-a]pyrimidine Mannich bases.
Aeluri R; Alla M; Polepalli S; Jain N
Eur J Med Chem; 2015 Jul; 100():18-23. PubMed ID: 26067381
[TBL] [Abstract][Full Text] [Related]
16. Discovery of diamine-linked 17-aroylamido-17-demethoxygeldanamycins as potent Hsp90 inhibitors.
Li Z; Jia L; Wang J; Wu X; Hao H; Wu Y; Xu H; Wang Z; Shi G; Lu C; Shen Y
Eur J Med Chem; 2014 Nov; 87():346-63. PubMed ID: 25277067
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of some azines of acetophenone derived mono-Mannich bases against Jurkat cells.
Gul HI; Gul M; Vepsälainen J; Erciyas E; Hänninen O
Biol Pharm Bull; 2003 May; 26(5):631-7. PubMed ID: 12736503
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic activities of some mono and bis Mannich bases derived from acetophenone in brine shrimp bioassay.
Gul HI; Gul M; Hänninen O
Arzneimittelforschung; 2002; 52(11):840-3. PubMed ID: 12489256
[TBL] [Abstract][Full Text] [Related]
19. Mannich bases of 1,2,4-triazole-3-thione containing adamantane moiety: Synthesis, preliminary anticancer evaluation, and molecular modeling studies.
Milošev MZ; Jakovljević K; Joksović MD; Stanojković T; Matić IZ; Perović M; Tešić V; Kanazir S; Mladenović M; Rodić MV; Leovac VM; Trifunović S; Marković V
Chem Biol Drug Des; 2017 Jun; 89(6):943-952. PubMed ID: 27933733
[TBL] [Abstract][Full Text] [Related]
20. Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives.
Tiwari SV; Siddiqui S; Seijas JA; Vazquez-Tato MP; Sarkate AP; Lokwani DK; Nikalje APG
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
